Outpatient Therapeutics
- March 25, 2022
-
Outpatient Therapeutics
DOH Advisory: Pause in Distribution of Sotrovimab - Read More
- March 4, 2022
-
Outpatient Therapeutics
DOH Advisory: Test Soon and Treat Early to Improve Outcomes from COVID-19 - Read More
- February 28, 2022
-
Outpatient Therapeutics
DOH Provides Information to LTC Providers on Accessing Antiviral Therapies DAL provides information on how to access oral antivirals for treatment of COVID-19.
- Read More
- February 22, 2022
-
Outpatient Therapeutics
DOH Letter on Availability of COVID-19 Therapeutics for Long Term Care Pharmacies - Read More
- January 24, 2022
-
Outpatient Therapeutics
Clinical Updates from DOH and CDC DOH issues new advisory on monoclonal antibody treatment recommendations and new vaccination screening checklist for individuals age 12 and over; CDC issues updated antigen testing guidance.
- Read More
- January 21, 2022
-
Outpatient Therapeutics
DOH Advisory on Updated COVID-19 Monoclonal Antibody Treatment Recommendations - Read More
- December 31, 2021
-
Outpatient Therapeutics
NYS Medicaid Policy and Billing Guidance for Pharmacy Reimbursement of COVID-19 Oral Antivirals - Read More
- December 29, 2021
-
Outpatient Therapeutics
NYS Medicaid Policy and Billing Guidance for Reimbursement of COVID-19 Monoclonal Antibody Therapeutic Dispensing or Administration at Pharmacies - Read More
- December 27, 2021
-
Outpatient Therapeutics
DOH Advisory on COVID-19 Oral Antiviral Treatments Authorized and Severe Shortage of Oral Antiviral and Monoclonal Antibody Treatment Products - Read More
- December 20, 2021
-
Outpatient Therapeutics
Prioritization of Anti-SARS-CoV-2 Monoclonal Antibodies for the Treatment and Prevention of Severe COVID-19 During Times of Severe Resource Limitations - Read More
-
- view more